Literature DB >> 5101777

Liver galactose-1-phosphate uridyl transferase: activity in normal and galactosemic subjects.

S Segal, S Rogers, P G Holtzapple.   

Abstract

The kinetic characteristics of galactose-l-phosphate uridyl transferase have been determined in homogenates of human liver biopsies obtained from control subjects and in 50-fold purified enzyme preparations from liver obtained at autopsy. A standardized assay procedure employing linear kinetics was used to assess the enzyme activity in homogenates of liver biopsy specimens from five control subjects and four patients with congential galactosemia with demonstrated absence of the enzyme activity in red blood cells. Activity of control specimens ranged from 11.8 to 17.2 mmumoles of UDPgalactose formed per min mg of protein. Liver of two galactosemic patients, both Caucasian, possessed no detectable enzyme activity (less than 1-2% of normal). The tissue of two others, both Negro, who are known to be capable of metabolizing intravenously administered galactose, contained easily detectable enzyme at approximately 10% of the controls. No alternate enzymatic activity for formation of UDPgalactose was found in the liver of Negroes with galactosemia that was as active as the residual galactose-l-phosphate uridyl transferase. The data suggest that the residual liver enzyme activity accounts for the ability of Negroes with galactosemia to metabolize limited but significantly large quantities of galactose.

Entities:  

Mesh:

Substances:

Year:  1971        PMID: 5101777      PMCID: PMC291956          DOI: 10.1172/JCI106518

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  13 in total

1.  THE METABOLISM OF GALACTOSE BY PATIENTS WITH CONGENITAL GALACTOSEMIA.

Authors:  S SEGAL; A BLAIR; H ROTH
Journal:  Am J Med       Date:  1965-01       Impact factor: 4.965

2.  Galactose metabolism: phenotypic differences among tissues of a patient with congenital galactosaemia.

Authors:  Y J TOPPER; L LASTER; S SEGAL
Journal:  Nature       Date:  1962-12-08       Impact factor: 49.962

3.  Galactosemia, a congenital defect in a nucleotide transferase.

Authors:  H M KALCKAR; E P ANDERSON; K J ISSELBACHER
Journal:  Biochim Biophys Acta       Date:  1956-04

4.  Evidence for accessory pathway of galactose metabolism in mammalian liver.

Authors:  K J ISSELBACHER
Journal:  Science       Date:  1957-10-04       Impact factor: 47.728

5.  Defect in uptake of galactose-1-phosphate into liver nucleotides in congenital galactosemia.

Authors:  E P ANDERSON; K J ISSELBACHER; H M KALCKAR
Journal:  Science       Date:  1957-01-18       Impact factor: 47.728

6.  SOME OBSERVATIONS ON THE METABOLISM OF D-GALACTOSE IN NORMAL MAN.

Authors:  S Segal; A Blair
Journal:  J Clin Invest       Date:  1961-11       Impact factor: 14.808

7.  Characteristics of galactose-1-phosphate uridyl transferase in intestinal mucosa of normal and galactosemic humans.

Authors:  S Rogers; P G Holtzapple; W J Mellman; S Segal
Journal:  Metabolism       Date:  1970-09       Impact factor: 8.694

Review 8.  Clinical variants of galactosemia.

Authors:  D Y Hsia
Journal:  Metabolism       Date:  1967-05       Impact factor: 8.694

9.  Human hepatic uridine diphosphate galactose pyrophosphorylase. Its characterization and activity during development.

Authors:  H D Abraham; R R Howell
Journal:  J Biol Chem       Date:  1969-02-25       Impact factor: 5.157

10.  Developmental aspects and some characteristics of mammalian galactose 1-phosphate uridyltransferase.

Authors:  D Bertoli; S Segal
Journal:  J Biol Chem       Date:  1966-09-10       Impact factor: 5.157

View more
  13 in total

Review 1.  Regulation of galactose metabolism: implications for therapy.

Authors:  S Segal; S Rogers
Journal:  J Inherit Metab Dis       Date:  1990       Impact factor: 4.982

2.  Komrower Lecture. Galactosaemia today: the enigma and the challenge.

Authors:  S Segal
Journal:  J Inherit Metab Dis       Date:  1998-08       Impact factor: 4.982

3.  Characteristics of galactokinase and galactose-1-phosphate uridyltransferase in cultivated fibroblasts and amniotic fluid cells.

Authors:  Y Shin-Buehring; H Leitner; H Henseleit; A Wirtz; B Haas; J Schaub
Journal:  Hum Genet       Date:  1979-04-17       Impact factor: 4.132

4.  Biochemical studies of a human low-activity galactose-1-phosphate uridyl transferase variant.

Authors:  W G Ng; F Kline; J Lin; R Koch; G N Donnell
Journal:  J Inherit Metab Dis       Date:  1978       Impact factor: 4.982

5.  Galactose-1-phosphate uridyl transferase in density-fractionated erythrocytes. Studies of normal and mutant enzymes.

Authors:  R I Kelley; D M Feinberg; S Segal
Journal:  Hum Genet       Date:  1989-05       Impact factor: 4.132

6.  Molecular analysis of 11 galactosemia patients.

Authors:  J K Reichardt
Journal:  Nucleic Acids Res       Date:  1991-12       Impact factor: 16.971

7.  Molecular characterization of two galactosemia mutations: correlation of mutations with highly conserved domains in galactose-1-phosphate uridyl transferase.

Authors:  J K Reichardt; S Packman; S L Woo
Journal:  Am J Hum Genet       Date:  1991-10       Impact factor: 11.025

8.  Galactose metabolism in transferase-deficient galactosaemic and normal long-term lymphoid cell lines.

Authors:  N G Beratis; L Wilbur
Journal:  J Inherit Metab Dis       Date:  1987       Impact factor: 4.982

Review 9.  Galactosemia unsolved.

Authors:  S Segal
Journal:  Eur J Pediatr       Date:  1995       Impact factor: 3.183

10.  Characterization of normal and abnormal variants of galactose-1-phosphate uridylyltransferase (EC 2.7.7.12) by isoelectric focusing.

Authors:  R I Kelley; H Harris; W J Mellman
Journal:  Hum Genet       Date:  1983       Impact factor: 4.132

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.